Literature DB >> 33738086

Bis[pyrrolyl Ru(ii)] triads: a new class of photosensitizers for metal-organic photodynamic therapy.

Deborah A Smithen1, Susan Monro2, Mitch Pinto2, John Roque3,4, Roberto M Diaz-Rodriguez1, Huimin Yin2, Colin G Cameron4, Alison Thompson1, Sherri A McFarland4.   

Abstract

A new family of ten dinuclear Ru(ii) complexes based on the bis[pyrrolyl Ru(ii)] triad scaffold, where two Ru(bpy)2 centers are separated by a variety of organic linkers, was prepared to evaluate the influence of the organic chromophore on the spectroscopic and in vitro photodynamic therapy (PDT) properties of the compounds. The bis[pyrrolyl Ru(ii)] triads absorbed strongly throughout the visible region, with several members having molar extinction coefficients (ε) ≥ 104 at 600-620 nm and longer. Phosphorescence quantum yields (Φ p) were generally less than 0.1% and in some cases undetectable. The singlet oxygen quantum yields (Φ Δ) ranged from 5% to 77% and generally correlated with their photocytotoxicities toward human leukemia (HL-60) cells regardless of the wavelength of light used. Dark cytotoxicities varied ten-fold, with EC50 values in the range of 10-100 μM and phototherapeutic indices (PIs) as large as 5400 and 260 with broadband visible (28 J cm-2, 7.8 mW cm-2) and 625 nm red (100 J cm-2, 42 mW cm-2) light, respectively. The bis[pyrrolyl Ru(ii)] triad with a pyrenyl linker (5h) was especially potent, with an EC50 value of 1 nM and PI > 27 000 with visible light and subnanomolar activity with 625 nm light (100 J cm-2, 28 mW cm-2). The lead compound 5h was also tested in a tumor spheroid assay using the HL60 cell line and exhibited greater photocytotoxicity in this more resistant model (EC50 = 60 nM and PI > 1200 with 625 nm light) despite a lower dark cytotoxicity. The in vitro PDT effects of 5h extended to bacteria, where submicromolar EC50 values and PIs >300 against S. mutans and S. aureus were obtained with visible light. This activity was attenuated with 625 nm red light, but PIs were still near 50. The ligand-localized 3ππ* state contributed by the pyrenyl linker of 5h likely plays a key role in its phototoxic effects toward cancer cells and bacteria. This journal is © The Royal Society of Chemistry 2020.

Entities:  

Year:  2020        PMID: 33738086      PMCID: PMC7953431          DOI: 10.1039/d0sc04500d

Source DB:  PubMed          Journal:  Chem Sci        ISSN: 2041-6520            Impact factor:   9.825


  65 in total

1.  Design aspects for the development of mixed-metal supramolecular complexes capable of visible light induced photocleavage of DNA.

Authors:  Alvin A Holder; Shawn Swavey; Karen J Brewer
Journal:  Inorg Chem       Date:  2004-01-12       Impact factor: 5.165

2.  Heteroleptic dipyrrin/bipyridine complexes of ruthenium(II).

Authors:  Serena J Smalley; Mark R Waterland; Shane G Telfer
Journal:  Inorg Chem       Date:  2009-01-05       Impact factor: 5.165

3.  Electrochemical and photophysical properties of DNA metallo-intercalators containing the ruthenium(II) tris(1-pyrazolyl)methane unit.

Authors:  Simon P Foxon; Clive Metcalfe; Harry Adams; Michelle Webb; Jim A Thomas
Journal:  Inorg Chem       Date:  2007-01-22       Impact factor: 5.165

Review 4.  Thomas J. Dougherty: An Appreciation.

Authors:  David Kessel
Journal:  Photochem Photobiol       Date:  2019-08-28       Impact factor: 3.421

5.  Photophysics of Ru(II) Dyads Derived from Pyrenyl-Substitued Imidazo[4,5-f][1,10]phenanthroline Ligands.

Authors:  Christian Reichardt; Mitch Pinto; Maria Wächtler; Mat Stephenson; Stephan Kupfer; Tariq Sainuddin; Julien Guthmuller; Sherri A McFarland; Benjamin Dietzek
Journal:  J Phys Chem A       Date:  2015-04-20       Impact factor: 2.781

6.  Strained ruthenium complexes are potent light-activated anticancer agents.

Authors:  Brock S Howerton; David K Heidary; Edith C Glazer
Journal:  J Am Chem Soc       Date:  2012-05-11       Impact factor: 15.419

7.  Mechanistic study on the photochemical "light switch" behavior of [Ru(bpy)2dmdppz]2+.

Authors:  Erin Wachter; Edith C Glazer
Journal:  J Phys Chem A       Date:  2014-07-24       Impact factor: 2.781

8.  Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433.

Authors:  Susan Monro; Katsuya L Colón; Huimin Yin; John Roque; Prathyusha Konda; Shashi Gujar; Randolph P Thummel; Lothar Lilge; Colin G Cameron; Sherri A McFarland
Journal:  Chem Rev       Date:  2018-10-08       Impact factor: 60.622

9.  Photo-Uncaging of a Microtubule-Targeted Rigidin Analogue in Hypoxic Cancer Cells and in a Xenograft Mouse Model.

Authors:  Vincent H S van Rixel; Vadde Ramu; Austin B Auyeung; Nataliia Beztsinna; David Y Leger; Lucien N Lameijer; Stan T Hilt; Sylvia E Le Dévédec; Tugba Yildiz; Tania Betancourt; M Brenton Gildner; Todd W Hudnall; Vincent Sol; Bertrand Liagre; Alexander Kornienko; Sylvestre Bonnet
Journal:  J Am Chem Soc       Date:  2019-11-06       Impact factor: 15.419

10.  Breaking the barrier: an osmium photosensitizer with unprecedented hypoxic phototoxicity for real world photodynamic therapy.

Authors:  John A Roque; Patrick C Barrett; Houston D Cole; Liubov M Lifshits; Ge Shi; Susan Monro; David von Dohlen; Susy Kim; Nino Russo; Gagan Deep; Colin G Cameron; Marta E Alberto; Sherri A McFarland
Journal:  Chem Sci       Date:  2020-08-03       Impact factor: 9.825

View more
  4 in total

1.  Ruthenium Photosensitizers for NIR PDT Require Lowest-Lying Triplet Intraligand (3IL) Excited States.

Authors:  Liubov M Lifshits; John A Roque; Elamparuthi Ramasamy; Randolph P Thummel; Colin G Cameron; Sherri A McFarland
Journal:  J Photochem Photobiol       Date:  2021-09-15

2.  Triazolyl Ru(II), Os(II), and Ir(III) complexes as potential HIV-1 inhibitors.

Authors:  Brandon Putterill; Charles Rono; Banothile Makhubela; Debra Meyer; Ntombenhle Gama
Journal:  Biometals       Date:  2022-06-14       Impact factor: 3.378

3.  An osmium-peroxo complex for photoactive therapy of hypoxic tumors.

Authors:  Nong Lu; Zhihong Deng; Jing Gao; Chao Liang; Haiping Xia; Pingyu Zhang
Journal:  Nat Commun       Date:  2022-04-26       Impact factor: 17.694

Review 4.  Progress of Nanomaterials in Photodynamic Therapy Against Tumor.

Authors:  Lei Chen; Jiahui Huang; Xiaotong Li; Miaoting Huang; Shaoting Zeng; Jiayi Zheng; Shuyi Peng; Shiying Li
Journal:  Front Bioeng Biotechnol       Date:  2022-05-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.